美亞柏科(300188.SZ):將對各類AIGC內容檢測、AI生成文本檢測技術及產品進行佈局
格隆匯5月5日丨有投資者在投資者互動平台向美亞柏科(300188.SZ)提問,“公司如何幫助人工智能數據合規和隱私安全?”
美亞柏科回覆稱,公司通過對人工智能算法、系統的安全性評估,按照《數據安全法》、《互聯網信息服務深度合成管理規定》等法律法規,佈局人工智能產品安全合規的評測技術。接下來公司將對各類 AIGC 內容的檢測、AI 生成文本的檢測技術及產品進行佈局,助力人工智能數據合規。此外,公司也將採用隱私計算和聯邦計算等計算結合人工智能的方式,增強數據訪問和交換的隱私安全。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.